Effects of short-term hormone replacement therapies on low-density lipoprotein metabolism in cynomolgus monkeys

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 17, Issue 6, 1997, Pages 1128-1134

  Wagner, Janice D ^a   Schwenke, Dawn C ^a   Zhang, Li ^a   Applebaum Bowden, Deborah ^a   Bagdade, John D ^b   Adams, Michael R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b RUSH UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Cholesterol; Cynomolgus monkeys; Estrogen; LDL metabolism; Liver; Progestin

Indexed keywords

CONJUGATED ESTROGEN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IODINE 125; LOW DENSITY LIPOPROTEIN; MEDROXYPROGESTERONE ACETATE; TRIACYLGLYCEROL;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; DRUG EFFECT; ESTROGEN BLOOD LEVEL; ESTROGEN THERAPY; FEMALE; HORMONE ACTION; ISCHEMIC HEART DISEASE; LIPOPROTEIN METABOLISM; MONKEY; NONHUMAN; PRIORITY JOURNAL;

EID: 0030986320     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.17.6.1128     Document Type: Article

References (50)

1. Stampfer MJ, Colditz GA. Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 1991;20:47-63.
2. Barrett-Connor E, Bush TL. Estrogen and coronary heart disease in women. JAMA. 1991;265:1861-1867.
3. Adams MR, Kaplan JR, Manuck SB, Koritnik DR, Parks JS, Wolfe MS, Clarkson TB. Inhibition of coronary artery atherosclerosis by 17-β estradiol in ovariectomized monkeys: lack of an effect of added progesterone. Arteriosclerosis. 1990;10:1051-1057.
4. Adams MR, Register TC, Golden DL, Wagner JD, Williams JK. Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis. Arterioscler Thromb Vase Bial 1997;17:217-222.
5. Wagner JD, Clarkson TB, St. Clair RW, Schwenke DC, Shively CA, Adams MR. Estrogen and progesterone replacement therapy reduces LDL accumulation in the coronary arteries of surgically postmenopausal cynomolgus monkeys. J Clin Invest. 1991; 88: 1995-2002.
6. Wagner JD, St. Clair RW, Schwenke DC, Shively CA, Adams MR, Clarkson TB. Regional differences in arterial low-density lipoprotein metabolism in surgically postmenopausal cynomolgus monkeys: effects of estrogen and progesterone therapy. Arterioscler Thromb. 1992;12:717-726.
7. Wagner JD, Adams MR, Schwenke DC, Clarkson TB. Oral contraceptive treatment decreases arterial LDL degradation in female cynomolgus monkeys. Circ Res. 1993;72:1300-1307.
8. Wagner JD, Zhang L, Williams JK, Register TC, Ackerman DM, Wiita B, Clarkson TB, Adams MR. Esterified estrogens with and without methyltestosterone decrease arterial LDL metabolism in cynomolgus monkeys. Arterioscler Thromb Vase Biol. 1996;16: 1473-1480.
9. Williams JK, Adams MR, Klopfenstein HS. Estrogen modulates responses of atherosclerotic coronary arteries. Circulation. 1990;81: 1680-1687.
10. Allain CC, Poon LS, Chan CSG, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20: 470-475.
11. Lipid Research Clinics Program. Manual of Laboratory Operations, Vol 1: Lipid and Lipoprotein Analysis. Bethesda, Md: National Heart, Lung, and Blood Institute, National Institutes of Health; 1974. US Dept of Health, Education, and Welfare publication 75-628. Revised 1982.
12. Fossati P, Principe L. Serum triglycerides determined colorimetrically with an enzyme that produces hydrogen peroxide. Clin Chem. 1982;28:2077-2080.
13. Parks JS, Gebre AK. Studies on the effect of dietary fish oil on the physical and chemical properties of low density lipoproteins in cynomolgus monkeys. J Lipid Res. 1991;32:305-315.
14. Auerbach BJ, Parks JS, Applebaum-Bowden D. A rapid and sensitive micro-assay for the enzymatic determination of plasma and lipoprotein cholesterol. J Lipid Res. 1990;31:738-742.
15. Carroll RM, Rudel LL. Lipoprotein separation and low density lipoprotein molecular weight determination using high performance gel-filtration chromatography. J Lipid Res. 1983;24:200-207.
16. Wagner JD, Martino MA, Jayo MJ, Anthony MS, Clarkson TB, Cefalu WT. The effects of hormone replacement therapy on carbohydrate metabolism and cardiovascular risk factors in surgically postmenopausal cynomolgus monkeys. Metabolism. 1996;45:1254-1262.
17. Applebaum-Bowden D, Haffner SM, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Hazzard WR. Postheparin plasma triglyceride lipases: relationships with very low density lipoprotein triglyceride and high density Iipoprotein2 cholesterol. Arteriosclerosis. 1985:5:273-282.
18. Bagdade ID, Wagner JD, Rudel LL, Clarkson TB. Accelerated cholesteryl ester transfer and altered lipoprotein composition in diabetic cynomolgus monkeys. J Lipid Res. 1995;36:759-766.
19. Lowry OH, Rosenbrough NJ, Fair AL, Randall RJ. Protein measurement with the Polin phenol reagent. J Biol Chem. 1951;193:265-275.
20. Schwenke DC, Carew TE. Quantification in vivo of increased LDL content and rate of LDL degradation in the normal rabbit aorta occurring at sites susceptible to early atherosclerotic lesions. Circ Res. I988;62:699-710.
21. Fraker PJ, Speck JC Jr. Protein and cell membrane iodination with a sparingly soluble chloroamide l,3,4,6-tetrachloro-3a,6a-diphenylglycouril. Biochem Biophys Res Commun. 1978;80:849-857.
22. Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can j Biochem Physiol. 1959;37:911-917.
23. Yedgar S, Carew TE, Pittman RC, Beltz WF, Steinberg D. Tissue sites of catabolism of albumin in rabbits. Am J Physiol. 1983;244: E101-E107.
24. Carew TE, Pittman RC, Marchand ER, Steinberg D. Measurement in vivo of irreversible degradation of low density lipoprotein in the rabbit aorta: predominance of intimai degradation. Arteriosclerosis. 1984:4:214-224.
25. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem. 1957;224:497-509.
26. Carr TP, Andresen CJ, Rudel LL. Enzymatic determination of triglyceride, free cholesterol, and total cholesterol in tissue lipid extracts. Clin Biochem. 1993;26:39-42.
27. Applebautn-Bowden D, McLean P, Steinmetz A, Fontana D, Matthys C, Warnick GR, Cheung M, Albers JJ, Hazzard WR. Lipoprotein, apoprotein, and lipolytic enzyme changes following estrogen administration in postmenopausal women. J Lipid Res. '1989:30:1895-1906.
28. Carew TEJ Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis. Proc Nail Acad Sei USA. 1987;84: 7725-7729.
29. Schwenke DC, Carew TE. Initiation of atherosclerotic lesions in cholesterol-fed rabbits, I: focal increases in arterial concentration precede development of fatty streak lesions. Arteriosclerosis. 1989; 9:895-907.
30. 125 I-tyramine cellobiose-labeled low density lipoprotein is greater in the atherosclerosis-susceptible region of white Carneau pigeon aorta and further enhanced once atherosclerotic lesions develop. Arterioscler Tliromb. 1992:12:446-460.
31. Subbiah MTR, Kessel B, Agrawal M, Rajan R, Abplanalp W, Rymaszewski Z. Antioxidant potential of specific estrogens on lipid peroxidation. J Clin Endocrinol Metab. 1993:77:1095-1097.
32. Sack MN, Rader DJ, Cannon RO III. Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women. Lancet. 1994:343:269-270.
33. Huber LA, Scheffler E, Poll T, Ziegler R, Dresel HA. 17β-Estradiol inhibits LDL oxidation and cholesteryl ester formation in cultured macrophages. Free Radie Res Commun. 1990;8:167-173.
34. Tomita T, Sawamura F, Uetsuka R, Chiba T, Miura S, Ikeda M, Tomita I. Inhibition of cholesteryl ester accumulation by 17β-estradiol in macrophages through activation of neutral cholesterol esterase. Biochem Biophys Ada. 1996; 1300:210-218.
35. Sacks FM, McPherson R, Walsh BW. Effect of poslmenopausal estrogen replacement on plasma Lp(a) lipoprotein concentrations. Arch Inlern Med. 1994;154:1106-1110.
36. Manning JM, Campos G, Edwards U, Wagner WD, Wagner JD, Adams MR, Parks JS. Effects of hormone replacement modalities on low density lipoprotein composition and distribution in ovariectomized cynomolgus monkeys. Atherosclerosis. 1996; 121:217-229.
37. van der Mooren MJ, de Graaf J, Demacker PN, de Haan AF, Rolland R. Changes in the low-density lipoprotein profile during 17β-estradiol-dydrogesterone therapy in postmenopausal women. Metabolism. 1994;43:799-802.
38. Campos H, Sacks FM, Walsh BW, Schiff I, O'Hanesian MA, Krauss RM. Differential effects of estrogen on low-density lipoprotein subclasses in healthy postmenopausal women.''Metabolism. I993;42: 1153-1158.
39. Campos H, McNamara JR, Wilson PWF, Ordovas JM, Schaefer EJ. Differences in low density lipoprotein subfractions and apolipoproteins in premenopausal and postmenopausal women. J Clin Endocrinol Melab. 1988;67:30-35.
40. Granfone A, Campos H, McNamara JR, Schaefer MM, Lamon-Fava S, Ordovas JM, Schaefer EJ. Effects of estrogen replacement on plasma lipoproteins and apolipoproteins in postmenopausal, dyslipidemic women. Metabolism. 1992;41:1193-1198.
41. Floren C-H, Kushwaha RS, Hazzard WR, Albers JJ. Estrogeninduced increase in uptake of cholesterol-rich very low density lipoproteins in perfused rabbit liver. Metabolism. 1981;30:367-375.
42. Demacker PNM, Mol MJTM, Stalenhoef AFH. Increased hepatic lipase activity and increased direct removal of very low density lipoprotein remnants in Watanabe heritable hyperlipidemic (WHHL) rabbits treated with ethinyl estradiol. Biochem J. 1990; 272:647-651.
43. Walsh B W, Schiff I, Rosner B, Greenberg L, Ravnikar V, Sacks FM. Effects of postmenopausal estrogen replacement on the concentrations and metabolism of plasma lipoproteins. N Engt J Med. 1991; 325:1196-1204.
44. Westerveld HT, Kock LAW, van Rijn JM, Erkelens DW, de Bruin TWA. 17β-Estradiol improves postprandial lipid metabolism in postmenopausal women. J Clin Endocrinol Melab. 1995;80:249-253.
45. Kushwaha RS, Foster DM, Barren PHR, Carey KD, Bernard MG. Metabolic regulation of plasma apolipoprotein E by estrogen and progesterone in the baboon (Papio sp). Metabolism. I991;40: 93-100.
46. Everson GT, McKinley C, Kern F Jr. Mechanisms of gallstone formation in women: effects of exogenous estrogen (Premarin) and dietary cholesterol on hepatic lipid metabolism. J Clin Invest. 1991; 87:237-246.
47. Kushwaha RS, Born KM. Effect of estrogen and progesterone on the hepatic cholesterol 7α-hydroxylase activity in ovariectomized baboons. Biochim Biophys Ada. 1991:1084:300-302.
48. Colvin PL Jr, Wagner JD, Adams MR, Sorci-Thomas MG. Sex steroid replacement increases hepatic 7 alpha-hydroxylase mRNA. Circulation. 1994;90(suppl I):1-351. Abstract.
49. Parks JS, Wilson MD, Johnson FL, Rudel LL. Fish oil decreases hepatic cholesteryl ester secretion but not apoB secretion in African green monkeys. J Lip Lipid Res. 1989:30:1535-1544.
50. Colvin PL, Wagner JD, Heuser MD, Sorci-Thomas MG. Oral contraceptives decrease hepatic cholesterol independent of the LDL receptor in nonhuman primates. Arterioscler Tliromb. 1993;13:1645-1649.